Advita Ortho Reports First Clinical Use of Activit-E® Humeral Liners
Plantation, Florida, USA — July 24, 2026 Advita Ortho has announced the first clinical use of Equinoxe® Reverse Shoulder...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Plantation, Florida, USA — July 24, 2026 Advita Ortho has announced the first clinical use of Equinoxe® Reverse Shoulder...
DRAPER, Utah, May 4, 2026 Ortho Development Corporation (ODEV) has announced the full commercial launch of the Trivicta® Hip...
ATLANTA, Feb. 23, 2026 — MiRus announced U.S. FDA 510(k) clearance and commercial launch of the IO™ Expandable Wedge...
Irvine, California | December 30, 2025 — Overture Orthopaedics, a U.S.-based medical device company specializing in joint preservation technologies,...
